# Pharmaids Pharm (NSE: PHARMAID) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/PHARMAID · Pivot · prices to 19 Oct 2026

With a market capitalisation of ₹113 Cr, it ranks 2604th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

Its return on equity was −24.6% in FY26. Promoters held 32.99% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹113 Cr |
| ROE | −24.6% (FY26) |
| ROCE | −24.2% (FY26) |
| Debt to equity | 0.44 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹19 Cr | −₹14 Cr |
| FY24 | ₹15 Cr | −₹12 Cr |
| FY23 | ₹0 Cr | −₹8 Cr |
| FY22 | ₹4 Cr | ₹0 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 32.99%
- Non-institutions: 67.01%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Parnax Lab](https://app.pivotnow.in/stock/PARNAXLAB) | ₹108.95 | ₹125 Cr | 10.6 | — |
| [Krebs Biochemicals and Industries](https://app.pivotnow.in/stock/KREBSBIO) | ₹57.16 | ₹123 Cr | — | — |
| [Makers Labs](https://app.pivotnow.in/stock/MAKERSL) | ₹209.00 | ₹123 Cr | 52.5 | — |
| [Godavari Drugs](https://app.pivotnow.in/stock/GODAVARI) | — | ₹120 Cr | — | — |
| [BALAXI PHARMACEUTICALS](https://app.pivotnow.in/stock/BALAXI) | ₹21.72 | ₹120 Cr | 83.5 | — |
| [Alpa Laboratories](https://app.pivotnow.in/stock/ALPA) | ₹51.75 | ₹109 Cr | 7.3 | — |

## Questions and answers

### What is the market cap of Pharmaids Pharm?

Pharmaids Pharm's market capitalisation is ₹113 Cr (₹113 Cr) at the 19 Oct 2026 close, ranking 2604th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Pharmaids Pharm?

Return on equity was −24.6% in FY26 and return on capital employed was −24.2% in FY26 (consolidated figures).

### Is Pharmaids Pharm a debt-free company?

No. Pharmaids Pharm's debt-to-equity ratio was 0.44 in FY26, with total debt of ₹12 Cr.

### What is the shareholding pattern of Pharmaids Pharm?

As of 30 Jun 2026: promoters 32.99%, non-institutions 67.01%.

### Who are Pharmaids Pharm's competitors?

The listed Pharma & Healthcare companies closest to Pharmaids Pharm by market cap are Parnax Lab, Krebs Biochemicals and Industries, Makers Labs, Godavari Drugs, BALAXI PHARMACEUTICALS and Alpa Laboratories.

### Is Pharmaids Pharm a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Pharmaids Pharm's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on PHARMAID against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.